Contraceptive Technology Update
RSSArticles
-
STD Quarterly: Test for STDs from single Pap specimen
-
Don’t count implants out: 2 options may take Norplant’s place
-
Standard Days Method: Family planning option
-
STD Quarterly: HIV vaccines: New generation may reduce transmission of virus
-
STD Quarterly: Clinical trials harmed by lack of informed consent
-
High demand, production delay limit Skyla IUD
Providers might need to seek other long-acting reversible contraceptive methods other than the new smaller levonorgestrel intrauterine device, Skyla. -
Nonhormonal options eyed for contraception
Enrollment for a 3,200-subject Phase III registration study has been completed for Amphora, a non-hormonal contraceptive gel. -
Boost HPV vaccination numbers — next generation is at risk
Vaccination for human papillomavirus (HPV) rates in US girls ages 13-17 failed to increase between 2011 and 2012. -
For gestational diabetes, check prior status
It is critical to address contraception at each interconception visit with women with prior gestational diabetes mellitus (GDM). -
Gonorrhea treatments offer 2 new options
Results of a trial conducted by the Centers for Disease Control and Prevention (CDC) and the National Institutes of Health indicate two new antibiotic regimens.